Misuse of neostigmine for reversal of neuromuscular block.
D004357:Drug Synergism; D006801:Humans; D007700:Kinetics; D009388:Neostigmine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D011950:Receptors, Cholinergic / Q000187:drug effects; D013390:Succinylcholine / Q000378:metabolism / Q000494:pharmacology; D014403:Tubocurarine / Q000037:antagonists & inhibitors
D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D011950:Receptors, Cholinergic; D009388:Neostigmine; D013390:Succinylcholine; D014403:Tubocurarine